The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

However, the authors note that the pathway "now places increased emphasis on establishing all four pillars of guideline-directed medical therapy (GDMT) for HFrEF in the hospital, when possible, along ...

In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...

Otherwise, treatment of comorbidities ... The hierarchy of medical treatments for HFrEF is a current area for guideline development in the UK, but the most recent European and North American ...

We advocate an accelerated approach to treatment optimisation to reduce symptoms ... of the optimisation of patients with VsMR. Heart failure guidelines support the pursuit of rhythm control in HFrEF ...

Background Acute kidney injury (AKI) in the context of acute decompensated heart failure (ADHF) encompasses a broad spectrum ...

The device targets an estimated $3.7 billion market for HFrEF treatment, a significant opportunity that has piqued the interest of analysts and investors alike. The company has demonstrated strong ...